Navigation Links
ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform
Date:4/30/2008

HALIFAX, April 30 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, unveiled today its DepoVax(TM) platform, a novel depot vaccine delivery system used to increase the efficacy and strength of vaccines. IVT has filed additional patents to protect the DepoVax(TM) concept.

"The results from our preclinical studies demonstrate that DepoVax(TM) is highly effective with a single dose," remarked Marc Mansour, vice president of research and development at IVT. "DepoVax(TM) is superior to conventional vaccine formulations in its ability to raise strong cellular and humoral immune responses to a variety of antigens, a hallmark of IVT's vaccine formulations."

DepoVax(TM) has been tested in pandemic influenza and therapeutic cancer models. The research shows DepoVax(TM)-vaccines deliver effective, long lasting results with only one dose.

DepoVax(TM) vaccines are readily amenable to commercialization. They can be manufactured in large batches, and are well suited for large scale distribution and long term storage. DepoVax(TM) vaccines are packaged and stored in a dry form, ensuring the stability of antigens which can otherwise be unstable in aqueous formulations. DepoVax(TM) vaccines are also easy to administer by health care practitioners, an important consideration for immunization programs targeting infectious diseases in a population.

"Our patented technology offers a dramatic boost to the effectiveness of existing vaccines," said Randal Chase, president and CEO of IVT. "An effective and easy-to-administer DepoVax(TM) vaccine would be a valuable tool for health authorities dealing with a pandemic and we are planning to take this into the clinic as soon as possible."

About IVT

ImmunoVaccine Technologies Inc. is a private, clinical-stage, vaccine development company. Through its own biotech research and collaborations with partners, IVT creates vaccines with the potential to help save and impr
'/>"/>

SOURCE ImmunoVaccine Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
2. ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
3. Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine
4. Sticky nanotubes hold key to future technologies
5. Adoption of Spinal Nonfusion Technologies Doubled in One Year
6. Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
7. VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales
8. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
9. Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008
10. Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones
11. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ON, Nov. 25 Biotech firm Replikins...data from the 1918 pandemic through the prediction...mic, today issued its latest biochemical analysis ...y of the H1N1 ("Swine Flu") virus has dropped from...rent outbreak in the spring of 2009 to resting non...
(Date:11/25/2009)...N, Nov. 25 /PRNewswire/ - Cytochroma today announc...d of Directors. Dr. Moldt will replace Mr. Ulrik S...,s Board. The number of Board members remains unch...o welcome Peter Moldt to the board and look forwar...s Cytochroma continues to make progress in becomin...
(Date:11/25/2009)..., Nov. 25 Ardea Bioscien...rry D. Quart, Pharm.D., president and chief execut...t Annual Health Care Conference. , ,Presentation ... Health Care Conference,Date: Tuesday, Decemb...ion: The New York Palace Hotel, New York, NY,Webc...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...o: David Appia, French Ambassador for Internationa...n France Agency, , , , ,What: Ambassador Appia is...o-business initiatives adopted by France to furthe...cape for innovation and development., , ,When: Ava...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... Keppra XR(TM) offers significant partial onset ...-daily dosing - Keppra XR(TM) is built...release, regulated information:,UCB announced toda... has,approved Keppra XR(TM) (levetiracetam extende...ntiepileptic treatments for people with partial-on...
...some Diagnostics, Inc. today,announced the appoint...,research. In this role, Dr. Skog will oversee the...elopment of its blood-based diagnostics that can,i...kog is the primary discoverer and inventor of Exos...nsed exclusively to the company by,Massachusetts G...
...yments and promotional investment totaling up to ... PALO ALTO, Calif., Sept. 12 CV Therapeutics,Inc....red into an agreement,granting exclusive rights to...in Europe and other countries to the Menarini Grou...ence, makes the most physician calls,for cardiovas...
Other Biology Technology:Video: Keppra XR(TM) Approved in the U.S. 2Video: Keppra XR(TM) Approved in the U.S. 3Video: Keppra XR(TM) Approved in the U.S. 4CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 2CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 3CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 4CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 5
(Date:11/24/2009)...f debate. A high-profile study a few years ago sug...rbon from trees and leaves, evidence for a very cl...stems. , But new research from the University of...lgae provide a much richer diet for fish and other...s week in the Proceedings of the National Academy...
(Date:11/23/2009)...Applied mathematicians dissected the morphology of...eristic long leaf with a saddle-like arc midsectio...simple cause of the lily,s fan-like shapeelastic r...al growthwas revealed by using an equally simple t..., a postdoctoral student at Harvard,s School of En...
(Date:11/23/2009)...incontrovertible evidence" that the volcanic super...3,000 years ago deforested much of central India, ...eport. , The volcano ejected an estimated 800 cu... a crater (now the world,s largest volcanic lake) .... Ash from the event has been found in India, the ...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Elevated water temperature and acidity boost growth of key sea star species 3A UBC researchers 8683 1Elevated water temperature and acidity boost growth of key sea star species 3A UBC researchers 8683 2Singapore scientists elected into National Academy of Sciences 8681 1Singapore scientists elected into National Academy of Sciences 8681 2Bringing Uninsured and Underinsured Issues Into the Spotlight in the Louisiana State Legislature 47506 1Bringing Uninsured and Underinsured Issues Into the Spotlight in the Louisiana State Legislature 47506 2Bringing Uninsured and Underinsured Issues Into the Spotlight in the Louisiana State Legislature 47506 3
...A system of opposing genetic forces determines why...ks sport several, according to a study published t...erstood, the genetic program described in the stud...and prevent cleft palate, one of the most common b... which information stored in genes is converted in...
...SAVANNAH, GABananas, known most often as a health...ants in the southern United States. Banana plants ...iful ornamentals used for creating a subtropical a...earch study published in the American Society for ...ailed a study of 33 commercial banana cultivars gr...
... New Haven, Conn. Global climate rapidly shifted ...ve ice sheets on Antarctica about 34 million years...ntists led by Yale geologists offers a new perspec... across this greenhouse-to-icehouse transitionone ...plications for predicting future climate changes. ...
Other Biology News:Scientists discover why teeth form in a single row 2Scientists discover why teeth form in a single row 3Scientists discover why teeth form in a single row 4Scientists discover why teeth form in a single row 5CO2 drop and global cooling caused Antarctic glacier to form 2
...Kits are designed for ultra-sensitive detection of...or PVDF membranes. Since all necessary reagents ar...s), the WesternBreeze Kits save you time in both o...ults. Solutions are pre-mixed and optimized to pro...
GIBCO Collagenase Type III from Invitrogen
Gold-plated 96-Well GeneAmp PCR System 9700 from Applied Biosystems
GolgiPlug from BD Biosciences Pharmingen
Biology Products: